Newsroom
Sorted by: Latest
-
AECOM appoints Dwight Pullen to lead its global Transportation business
DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM), the trusted global infrastructure leader, today announced it has appointed Dwight Pullen as Transportation Global Business Line Chief Executive, effective immediately. In this role, Mr. Pullen will lead AECOM’s global Transportation business, which is ranked No. 1 by Engineering News-Record. He assumes the role as AECOM pursues a growing pipeline of Transportation projects globally, with particularly strong growth prospects in the United States, Canad...
-
Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio’s Radiopharmaceutical Therapy, in Patients with GEP-NETs
PRINCETON, N.J.--(BUSINESS WIRE)--BMS Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 09.10.2026 UIGB IE00079WNSI6 2,915.00 GBP 77,797.93 26.689 ...
-
Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx NextG UCITS ETF 09.10.2026 NXTG.LN IE00BWTNM743 170,002.00 USD 9,737,010.46 57.276 ...
-
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that Bausch + Lomb Board of Directors Chairman Thomas J. Appio has been appointed interim chief executive officer, effective immediately. Appio will continue to serve as CEO of Bausch Health while assuming leadership of Bausch + Lomb. Appio was appointed chairman of the Bausch + Lomb Board of Dir...
-
Avery Dennison Names Helen Sheirbon President, Solutions Group
MENTOR, Ohio--(BUSINESS WIRE)--Avery Dennison Names Helen Sheirbon President, Solutions Group...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-
Cable One Provides Update on the Pending Purchase of Mega Broadband
PHOENIX--(BUSINESS WIRE)--Cable One, Inc. (NYSE: CABO) (“Cable One” or the “Company”) today announced that, on October 9, 2026, the United States District Court for the Southern District of New York entered a temporary restraining order (the “TRO”) that temporarily prohibits Cable One from acquiring the 55% of Mega Broadband Investments Holdings LLC (“MBI”) that it does not currently own. The action was commenced by CoBank, ACB, a lender under the Company's existing credit agreement. The compla...
-
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the successful completion of patient enrollment in the BIOMAG™-LL Clinical Study, evaluating the safety and clinical performance of the Freesolve™ Resorbable Magnesium Scaffold (RMS) in 35 mm and 40 mm lengths for the treatment of de novo coronary lesions up to 38 mm. The study reflects Teleflex's commitment to expanding clinical evidence supporting the use of the F...